- Home
- GRO vs SOPH Comparison
GRO vs SOPH Comparison
Compare GRO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRO
- SOPH
- Stock Information
- Founded
- GRO 2006
- SOPH 2011
- Country
- GRO Canada
- SOPH Switzerland
- Employees
- GRO N/A
- SOPH N/A
- Industry
- GRO
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRO
- SOPH Health Care
- Exchange
- GRO NYSE
- SOPH Nasdaq
- Market Cap
- GRO 256.9M
- SOPH 226.6M
- IPO Year
- GRO 2024
- SOPH 2021
- Fundamental
- Price
- GRO $6.64
- SOPH $3.12
- Analyst Decision
- GRO Strong Buy
- SOPH Strong Buy
- Analyst Count
- GRO 1
- SOPH 3
- Target Price
- GRO $17.00
- SOPH $7.00
- AVG Volume (30 Days)
- GRO 87.5K
- SOPH 39.5K
- Earning Date
- GRO 02-03-2025
- SOPH 03-04-2025
- Dividend Yield
- GRO N/A
- SOPH N/A
- EPS Growth
- GRO N/A
- SOPH N/A
- EPS
- GRO N/A
- SOPH N/A
- Revenue
- GRO N/A
- SOPH $64,488,000.00
- Revenue This Year
- GRO N/A
- SOPH $6.93
- Revenue Next Year
- GRO N/A
- SOPH $13.55
- P/E Ratio
- GRO N/A
- SOPH N/A
- Revenue Growth
- GRO N/A
- SOPH 9.85
- 52 Week Low
- GRO $6.50
- SOPH $2.70
- 52 Week High
- GRO $15.00
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- GRO N/A
- SOPH 47.70
- Support Level
- GRO N/A
- SOPH $2.88
- Resistance Level
- GRO N/A
- SOPH $3.60
- Average True Range (ATR)
- GRO 0.00
- SOPH 0.25
- MACD
- GRO 0.00
- SOPH 0.01
- Stochastic Oscillator
- GRO 0.00
- SOPH 33.05
About GRO BRAZIL POTASH CORP
Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company includes focusing on the extraction and processing of potash ore from underground mine and selling and distributing the processed potash in Brazil.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.